BioSpace News Archive

FamilyWize announced today a partnership that will give the public greater access to personalized medicine, helping patients better understand how their unique genetic profiles can influence how they metabolize certain medications.

Hookipa and Gilead will jointly develop therapeutics against HIV and Hepatitis B infections; Hookipa and Gilead will jointly research and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead

Complete healthcare and support services to children, regardless of family income

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that the company will present a new risk/benefit analysis from pooled Phase 3 study data evaluating TRULANCE® (plecanatide) and linaclotide for the treatment of adults with chronic idiopathic constipation (CIC).

Offering paid leave for living donation helps remove financial barriers

Sprig announces the immediate availability of the company’s new CBD-infused beverage line.

According to a report by Ameri Research Inc., the global legal cannabis market was valued at USD 14.3 billion in 2016 and is projected to grow at a CAGR of 21.1% between 2017 to 2024, while reaching a value of USD 63.5 billion by 2024.

Digipath, Inc. is pleased to announce that Mr. Rene Adler has joined its Las Vegas laboratory as its Analytical Laboratory Manager with oversight of the ISO 17025:2017 quality management system.

Supports company’s clinical, product development and regulatory efforts Michael Peterson, CTO Merz Device Innovation Center, joins Board of Directors

IDEAYA Biosciences, Inc. announced the appointment of Paul Stone, J.D., as senior vice president and general counsel, head of operations, and of Mark Lackner, Ph.D. as vice president and head of biomarkers and synthetic lethal biology.